Megamox 625 Mg 14 Tablets

Megamox 625 Mg 14 Tablets

Description:

Megamox 625 mg 14 tablets is a prescription systemic antibiotic medicine containing amoxicillin and clavulanic acid. It belongs to the penicillin class and is used to treat a wide range of bacterial infections, especially those caused by beta-lactamase–producing organisms that are resistant to amoxicillin alone. Megamox 625 mg is commonly prescribed for respiratory tract infections, sinus infections, ear infections, urinary tract infections, and skin and soft tissue infections in adults and adolescents, under medical supervision.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by culture and sensitivity testing, according to physician judgment.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – 500 mg per film-coated tablet
• Clavulanic acid (as potassium clavulanate) – 125 mg per film-coated tablet
• Total strength per tablet – 625 mg
• Excipients: tablet core and film-coating excipients (full excipient list is not available in the provided information; please refer to the package leaflet for complete details).

Dosage & Administration / How to Use:

• Use Megamox 625 mg only as prescribed by a physician and according to local treatment guidelines.
• Typical adult dose (including elderly) for many infections: 1 tablet (625 mg) every 8–12 hours, depending on infection severity and renal function, as directed by the doctor. Exact dosing regimen must be individualized by the prescriber.
• Tablets should preferably be taken at the start of a meal to improve absorption and help reduce potential gastrointestinal side effects.
• Swallow the tablet whole with a glass of water; do not crush or chew unless your doctor or pharmacist advises otherwise.
• Duration of treatment usually ranges from 5 to 14 days depending on the type and severity of infection; always complete the full prescribed course even if symptoms improve earlier.
• In patients with renal or hepatic impairment, dose adjustment or extended dosing interval may be required; follow physician instructions carefully.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

• Provides broad-spectrum antibacterial coverage against many gram-positive and gram-negative bacteria, including beta-lactamase–producing strains.
• Combines amoxicillin with clavulanic acid to overcome resistance caused by beta-lactamase enzymes, improving treatment success in resistant infections.
• Effectively treats common respiratory infections such as sinusitis, otitis media, bronchitis, and pneumonia when caused by susceptible organisms.
• Helps control and resolve symptoms associated with bacterial infections, such as fever, pain, inflammation, cough, and urinary discomfort.
• Reduces the risk of infection spread and complications when used appropriately and for the full prescribed duration.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity or allergy to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with extreme caution in patients with a history of severe immediate hypersensitivity reactions (e.g., anaphylaxis) to beta-lactam antibiotics such as cephalosporins or carbapenems.
• Contraindicated in patients with a history of jaundice or hepatic dysfunction associated with amoxicillin/clavulanate use.
• Use cautiously in patients with liver disease or hepatic impairment; periodic monitoring of liver function may be required.
• Use cautiously in patients with renal impairment; dose adjustment and monitoring of renal function may be necessary.
• Antibiotic-associated colitis (including Clostridioides difficile–associated diarrhea) may occur; discontinue and seek medical advice if severe or persistent diarrhea develops.
• Prolonged use may lead to overgrowth of non-susceptible organisms, including fungi; clinical monitoring is recommended in long courses.
• May interfere with some laboratory tests (e.g., urine glucose tests using non-enzymatic methods); inform laboratory staff you are taking amoxicillin/clavulanic acid.
• Consult your doctor before use if pregnant or planning pregnancy; use only if clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding; small amounts of amoxicillin and clavulanic acid are excreted in breast milk and may cause sensitization, diarrhea, or fungal infection in the infant.
• Inform your doctor about all medications you are taking, especially anticoagulants (e.g., warfarin), allopurinol, probenecid, methotrexate, or other antibiotics, due to potential interactions.
• Not intended for viral infections such as common cold or influenza; inappropriate use of antibiotics can promote bacterial resistance.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal discomfort, soft stools, and mild skin rash.
• Less common side effects: headache, dizziness, indigestion, flatulence, oral or vaginal candidiasis (thrush), and changes in taste.
• Rare but serious side effects: severe allergic reactions (anaphylaxis, angioedema, bronchospasm), severe skin reactions (Stevens–Johnson syndrome, toxic epidermal necrolysis), severe or persistent diarrhea possibly indicating antibiotic-associated colitis, liver dysfunction or hepatitis, jaundice, blood disorders (e.g., thrombocytopenia, leukopenia), and seizures (mainly in patients with renal impairment or high doses).
• Stop the medication and seek immediate medical attention if you experience difficulty breathing, swelling of the face or throat, severe skin rash, yellowing of the skin or eyes, dark urine, severe abdominal pain, or persistent bloody or watery diarrhea.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the original carton to protect from light. Do not store above the temperature specified on the package (refer to the product box; exact temperature is not available in the provided information). Keep container tightly closed and keep out of reach of children. Do not use after the expiry date printed on the pack.

Specifications:

• Product type: Prescription systemic antibiotic medicine (amoxicillin/clavulanic acid).
• Strength: 625 mg per film-coated tablet (amoxicillin 500 mg + clavulanic acid 125 mg).
• Form: Film-coated tablets.
• Pack size: 14 tablets per pack.
• Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.